Skip to main content
. Author manuscript; available in PMC: 2011 Jan 1.
Published in final edited form as: Neuropharmacology. 2009 Jul 9;58(1):88–101. doi: 10.1016/j.neuropharm.2009.06.040

Table 2.

This table summarize results from the NAc mid acquisition (session 5) analyzed by gcRMA.

Gene Title Fold Change
arginine vasopressin −14.7
ATPase, Na+K+ transporting, alpha 3 subunit −3.9
calcium channel beta 1 subunit −3.4
Calreticulin −2.3
chondroitin sulfate proteoglycan 5 −5.3
cyclase-associated protein homologue −2.2
ecto-apyrase 10
Fyn proto-oncogene −2.5
glucocorticoid modulatory element binding protein 2 2.2
Glutamate receptor, ionotropic, kainate 5 −2.2
glutamate receptor, metabotropic 5 −2.5
guanine nucleotide binding protein, alpha 12 −2.5
guanine nucleotide binding protein, gamma 7 −2.6
huntingtin-associated protein 1 −2.2
huntingtin-associated protein interacting protein (duo) −2.5
Myelin basic protein −15.1
Myomegalin −2
neural F box protein NFB42 −2.5
nuclear receptor subfamily 4, group A, member 3 2.4
PAK-interacting exchange factor beta −3.7
phosphatidylinositol 4-kinase −2.9
pre-alpha-inhibitor, heavy chain 3 −2
protein kinase inhibitor, alpha 2
protein phospatase 3, regulatory subunit B, alpha isoform,type 1 −3.6
R.norvegicus mRNA for GABA-BR1a receptor. −3.4
Rattus norvegicus GIRK2A-3 gene for GIRK2A, complete cds. 2
SNRPN upstream reading frame −2.2
solute carrier family 4, member 3 −2.4
somatostatin receptor 2 3.4
sphingosine 1-phosphate receptor −2.5
syntaxin 1a 2.9
v-akt murine thymoma viral oncogene homolog 1 −3.2
vesicular inhibitory amino acid transporter −3.5
Wolfram syndrome 1 −2.2